Is my portfolio
One Report to Answer all your Questions!
Natco Pharma Ltd.
BSE: 524816 | NSE: NATCOPHARM
Small Cap | Pharmaceuticals & Drugs
929.65
6.00 (0.65%) Natco Pharma - Quaterly Results
Date: 09-02-2023
The sales declined to Rs. 4130.00 millions for the December 2022 quarter as compared to Rs. 5295.00 millions during the corresponding quarter last year.Net profit of the cmpany stood at Rs. 373.00 millions for the quarter ended December 2022 a decline of -47.91% from Rs. 716.00 millions in the same quarter last year.The company reported a degrowth in operating Profit to 861.00 millions from 1193.00 millions.
(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202212 | 202112 | % Var | 202212 | 202112 | % Var | 202203 | 202103 | % Var | |
| Sales | 4130.00 | 5295.00 | -22.00 | 15698.00 | 12537.00 | 25.21 | 17678.00 | 16535.00 | 6.91 |
| Other Income | 186.00 | 316.00 | -41.14 | 680.00 | 842.00 | -19.24 | 946.00 | 1011.00 | -6.43 |
| PBIDT | 861.00 | 1193.00 | -27.83 | 5850.00 | 3349.00 | 74.68 | 3076.00 | 5187.00 | -40.70 |
| Interest | 30.00 | 41.00 | -26.83 | 74.00 | 91.00 | -18.68 | 133.00 | 113.00 | 17.70 |
| PBDT | 831.00 | 1152.00 | -27.86 | 5776.00 | 3258.00 | 77.29 | 2943.00 | 5074.00 | -42.00 |
| Depreciation | 381.00 | 355.00 | 7.32 | 1133.00 | 1028.00 | 10.21 | 1384.00 | 1152.00 | 20.14 |
| PBT | 450.00 | 797.00 | -43.54 | 4643.00 | 2230.00 | 108.21 | 1559.00 | 3922.00 | -60.25 |
| TAX | 77.00 | 81.00 | -4.94 | 813.00 | 226.00 | 259.73 | 168.00 | 827.00 | -79.69 |
| Deferred Tax | -3.00 | -61.00 | -95.08 | -19.00 | -171.00 | -88.89 | -157.00 | -106.00 | 48.11 |
| PAT | 373.00 | 716.00 | -47.91 | 3830.00 | 2004.00 | 91.12 | 1391.00 | 3095.00 | -55.06 |
| Equity | 365.00 | 365.00 | 0.00 | 365.00 | 365.00 | 0.00 | 365.00 | 365.00 | 0.00 |
| PBIDTM(%) | 20.85 | 22.53 | -7.47 | 37.27 | 26.71 | 39.51 | 17.40 | 31.37 | -44.53 |